Sorrento Therapeutics CEO Dr. Ji to Present at LEERINK Partners 9th Global Healthcare Conference

NEXT STORY
Vaxil Announces Financing Update
PREV STORY
EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AzurRx Announces Addition of Dr. Vern Lee Schramm to the Board of Directors

NEW YORK, Oct. 16, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...

author_avatar
NASDAQ Market News

Harpoon Therapeutics Doses First Patient with HPN328, an Anti-DLL3 T Cell Engager for Treatment of Small Cell Lung Cancer and other DLL3-Associated Tumors

author_avatar
NASDAQ Market News

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on March 30, 2021

author_avatar
NASDAQ Market News